SeaStar Medical Holding Co. (NASDAQ:ICU) Sees Large Increase in Short Interest

SeaStar Medical Holding Co. (NASDAQ:ICU) was the recipient of a large growth in short interest in the month of June. As of June 30th, there was short interest totalling 231,800 shares, a growth of 98.0% from the June 15th total of 117,100 shares. Approximately 8.1% of the company’s stock are short sold. Based on an average daily volume of 269,800 shares, the days-to-cover ratio is currently 0.9 days.

SeaStar Medical Trading Up 12.3 %

Shares of NASDAQ ICU traded up $0.94 during mid-day trading on Friday, hitting $8.60. The company had a trading volume of 418,585 shares, compared to its average volume of 255,401. The company has a market capitalization of $27.70 million, a PE ratio of -0.34 and a beta of -1.07. The firm has a 50-day simple moving average of $8.22 and a two-hundred day simple moving average of $14.54. SeaStar Medical has a one year low of $3.25 and a one year high of $42.92.

SeaStar Medical (NASDAQ:ICU) last announced its quarterly earnings data on Tuesday, May 14th. The company reported ($4.75) earnings per share for the quarter.

About SeaStar Medical

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.